DMAC
Price
$3.68
Change
-$0.28 (-7.07%)
Updated
Apr 3 closing price
Capitalization
157.71M
46 days until earnings call
PCVX
Price
$30.04
Change
-$0.52 (-1.70%)
Updated
Apr 4, 10:43 AM (EDT)
Capitalization
3.93B
38 days until earnings call
Ad is loading...

DMAC vs PCVX

Header iconDMAC vs PCVX Comparison
Open Charts DMAC vs PCVXBanner chart's image
DiaMedica Therapeutics
Price$3.68
Change-$0.28 (-7.07%)
Volume$85.7K
Capitalization157.71M
Vaxcyte
Price$30.04
Change-$0.52 (-1.70%)
Volume$2.06K
Capitalization3.93B
DMAC vs PCVX Comparison Chart
Loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DMAC vs. PCVX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a Hold and PCVX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (DMAC: $3.68 vs. PCVX: $30.56)
Brand notoriety: DMAC and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 97% vs. PCVX: 254%
Market capitalization -- DMAC: $157.71M vs. PCVX: $3.93B
DMAC [@Biotechnology] is valued at $157.71M. PCVX’s [@Biotechnology] market capitalization is $3.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than DMAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 4 TA indicator(s) are bullish while PCVX’s TA Score has 4 bullish TA indicator(s).

  • DMAC’s TA Score: 4 bullish, 5 bearish.
  • PCVX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than DMAC.

Price Growth

DMAC (@Biotechnology) experienced а -11.11% price change this week, while PCVX (@Biotechnology) price change was -56.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

DMAC is expected to report earnings on May 20, 2025.

PCVX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($3.93B) has a higher market cap than DMAC($158M). DMAC YTD gains are higher at: -32.228 vs. PCVX (-62.668). DMAC has higher annual earnings (EBITDA): -24.07M vs. PCVX (-448.08M). PCVX has more cash in the bank: 1.75B vs. DMAC (50.2M). DMAC has less debt than PCVX: DMAC (365K) vs PCVX (71.1M). DMAC (0) and PCVX (0) have equivalent revenues.
DMACPCVXDMAC / PCVX
Capitalization158M3.93B4%
EBITDA-24.07M-448.08M5%
Gain YTD-32.228-62.66851%
P/E RatioN/AN/A-
Revenue00-
Total Cash50.2M1.75B3%
Total Debt365K71.1M1%
FUNDAMENTALS RATINGS
DMAC: Fundamental Ratings
DMAC
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DMACPCVX
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LASGX14.10N/A
N/A
Lord Abbett International Growth R4
CAEIX10.48N/A
N/A
Calvert Global Energy Solutions I
JEMNX9.37N/A
N/A
JHancock Emerging Markets Equity R4
GRHIX12.98N/A
N/A
Goehring & Rozencwajg Resources Instl
VVOSX21.21N/A
N/A
Invesco Value Opportunities R6

DMAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with WHWK. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then WHWK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
-7.07%
WHWK - DMAC
42%
Loosely correlated
-3.53%
VTGN - DMAC
29%
Poorly correlated
-4.60%
AVXL - DMAC
26%
Poorly correlated
-3.04%
PCVX - DMAC
26%
Poorly correlated
-9.29%
ATYR - DMAC
26%
Poorly correlated
-5.74%
More